Survival
|
Survival or death
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
Neurologic exam at discharge
|
Neurologically normal or abnormal
|
X
|
X
| | | | | |
Cranial Ultrasonography
|
Cranial USS abnormality
|
X
|
X
| | | | | |
Neurologic examination at clinic visits
|
Malawi Developmental Assessment Tool (MDAT) scores
| | |
X
|
X
|
X
|
X
|
X
|
Laboratory levels of EPO, NRBC, and NRBC/100 WBC
|
Levels of NRBC and NRBC/100WBC in relation to outcome
|
X
|
X
| | | | | |
Adverse reactions to EPO
|
Safety of the medications based on the presence or absence of any adverse event
| |
X
|
X
|
X
|
X
|
X
|
X
|
Gross Motor Function Classification System (GMFCS) assessment system
|
Those with cerebral palsy are further categorized based on features present on standardized neurologic examination using GMFCS
| | |
X
|
X
|
X
|
X
|
X
|